- Home
- CRVS vs WIW Comparison
CRVS vs WIW Comparison
Compare CRVS & WIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- WIW
- Stock Information
- Founded
- CRVS 2014
- WIW 2004
- Country
- CRVS United States
- WIW United States
- Employees
- CRVS N/A
- WIW N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- WIW Finance Companies
- Sector
- CRVS Health Care
- WIW Finance
- Exchange
- CRVS Nasdaq
- WIW Nasdaq
- Market Cap
- CRVS 459.0M
- WIW 540.9M
- IPO Year
- CRVS 2016
- WIW N/A
- Fundamental
- Price
- CRVS $8.79
- WIW $8.73
- Analyst Decision
- CRVS Strong Buy
- WIW
- Analyst Count
- CRVS 4
- WIW 0
- Target Price
- CRVS $13.75
- WIW N/A
- AVG Volume (30 Days)
- CRVS 1.0M
- WIW 229.9K
- Earning Date
- CRVS 11-04-2025
- WIW 01-01-0001
- Dividend Yield
- CRVS N/A
- WIW 11.14%
- EPS Growth
- CRVS N/A
- WIW N/A
- EPS
- CRVS N/A
- WIW N/A
- Revenue
- CRVS N/A
- WIW N/A
- Revenue This Year
- CRVS N/A
- WIW N/A
- Revenue Next Year
- CRVS N/A
- WIW N/A
- P/E Ratio
- CRVS N/A
- WIW N/A
- Revenue Growth
- CRVS N/A
- WIW N/A
- 52 Week Low
- CRVS $2.54
- WIW $8.01
- 52 Week High
- CRVS $9.55
- WIW $9.37
- Technical
- Relative Strength Index (RSI)
- CRVS 63.66
- WIW 38.04
- Support Level
- CRVS $8.34
- WIW $8.63
- Resistance Level
- CRVS $9.22
- WIW $8.86
- Average True Range (ATR)
- CRVS 0.55
- WIW 0.07
- MACD
- CRVS 0.01
- WIW -0.01
- Stochastic Oscillator
- CRVS 83.41
- WIW 32.79
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About WIW Western Asset Inflation-Linked Opportunities & Income Fund
Western Asset Inflation-Linked Opportunities and Income Fund is a diversified, closed-end management investment company. Its primary investment objective of the group is to provide current income for its shareholders. The secondary investment objective is capital appreciation with current income.